A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection

Clinical trial NCT04706923 · COMPLETED

Trial details

NCT number: NCT04706923
Sponsor: SymBio Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenovirus Infections Cytomegalovirus Infection

Start date: 2021-08-16
Primary completion: 2025-05-15
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.